|
EP1123314B1
(en)
*
|
1998-10-20 |
2004-02-18 |
Vlaams Interuniversitair Instituut voor Biotechnologie vzw. |
Use of a cytokine-producing lactococcus strain to treat colitis
|
|
AUPQ291499A0
(en)
*
|
1999-09-17 |
1999-10-07 |
Women's And Children's Hospital Adelaide |
Novel nitro and sulphur containing compounds
|
|
NO328803B1
(no)
*
|
2000-03-03 |
2010-05-18 |
Thia Medica |
Nye fettsyreanaloger
|
|
JP5048201B2
(ja)
|
2000-08-04 |
2012-10-17 |
ディーエムアイ バイオサイエンシズ インコーポレイテッド |
ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物
|
|
NO20006008L
(no)
*
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
US7780961B2
(en)
*
|
2001-05-03 |
2010-08-24 |
Actogenix N.V. |
Self-containing Lactococcus strain
|
|
DK1571970T3
(da)
*
|
2002-10-02 |
2011-11-28 |
Dmi Biosciences Inc |
Diagnose og monitorering af sygdomme
|
|
AU2003298291A1
(en)
*
|
2002-11-15 |
2004-06-15 |
Universiteit Gent |
Self-containing lactobacillus strain
|
|
GB0311081D0
(en)
*
|
2003-05-14 |
2003-06-18 |
Btg Internat Limted |
Treatment of neurodegenerative conditions
|
|
CN102210852B
(zh)
|
2003-05-15 |
2016-10-19 |
安皮奥制药股份有限公司 |
T-细胞介导的疾病的治疗
|
|
EP2324828A1
(en)
*
|
2003-08-18 |
2011-05-25 |
BTG International Limited |
Treatment for neurodegenerative conditions
|
|
DE10351111A1
(de)
*
|
2003-11-03 |
2005-06-16 |
Langlotz, Rainer |
Arzneimittel und Verfahren zu ihrer Herstellung
|
|
JP2007522118A
(ja)
*
|
2004-01-30 |
2007-08-09 |
ペプリン バイオリピッズ ピーティーワイ エルティーディー |
治療用分子および担体分子
|
|
US7544714B2
(en)
*
|
2004-07-16 |
2009-06-09 |
University Of Massachusetts |
Lipid-amino acid conjugates and methods of use
|
|
GB0425932D0
(en)
*
|
2004-11-25 |
2004-12-29 |
Btg Int Ltd |
Structured phospholipids
|
|
GB0504333D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Treatment of cytokine dysregulation
|
|
GB0504362D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Cytokine modulators
|
|
US20060246115A1
(en)
*
|
2005-03-04 |
2006-11-02 |
Ricardo Rueda |
Nutritional products for ameliorating symptoms of rheumatoid arthritis
|
|
DK2119450T3
(da)
|
2005-11-29 |
2013-05-06 |
Actogenix Nv |
Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
|
|
BRPI0807857A2
(pt)
|
2007-01-25 |
2014-05-27 |
Actogenix Nv |
Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
|
|
WO2009006668A1
(en)
*
|
2007-02-05 |
2009-01-15 |
Children, Youth And Women's Health Service |
Modulators of antigen-dependent t cell proliferation
|
|
WO2009061208A1
(en)
|
2007-11-09 |
2009-05-14 |
Pronova Biopharma Norge As |
Lipid compounds for use in cosmetic products, as food supplement or as a medicament
|
|
JP5856843B2
(ja)
*
|
2008-05-27 |
2016-02-10 |
アンピオ ファーマシューティカルズ，インコーポレイテッド |
ジケトピペラジンを用いた医薬組成物
|
|
EP2147910A1
(en)
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
KR101783817B1
(ko)
*
|
2009-05-08 |
2017-10-23 |
프로노바 바이오파마 너지 에이에스 |
심혈관 질병, 대사 질병, 및 염증성 질환 분야관련 질병의 치료를 위한 다중 불포화 지방산
|
|
GB0909643D0
(en)
|
2009-06-04 |
2009-07-22 |
Avexxin As |
Glomerulonephritis treatment
|
|
GB201014633D0
(en)
|
2010-09-02 |
2010-10-13 |
Avexxin As |
Rheumatoid arthritis treatment
|
|
EP2613786A4
(en)
|
2010-09-07 |
2013-10-23 |
Dmi Acquisition Corp |
TREATMENT OF DISEASES
|
|
SG10201509127YA
(en)
|
2010-11-05 |
2015-12-30 |
Pronova Biopharma Norge As |
Methods of treatment using lipid compounds
|
|
JP2014530063A
(ja)
|
2011-10-10 |
2014-11-17 |
アンピオ ファーマシューティカルズ，インコーポレイテッド |
免疫寛容が高められた埋込み型医療用デバイス、ならびに製造方法および埋込み方法
|
|
PH12014500685B1
(en)
|
2011-10-10 |
2018-10-03 |
Ampio Pharmaceuticals Inc |
Treatment of degenerative joint disease
|
|
HK1198812A1
(en)
|
2011-10-28 |
2015-06-12 |
Ampio Pharmaceuticals, Inc. |
Treatment of rhinitis
|
|
GB201205394D0
(en)
|
2012-03-27 |
2012-05-09 |
Adlens Ltd |
Improvements in or relating to deformable non-round membrane assemblies
|
|
JP6248092B2
(ja)
|
2012-03-30 |
2017-12-13 |
ジボダン エス エー |
食品フレーバー付与化合物としてのｎ−アシル化１−アミノシクロアルキルカルボン酸
|
|
WO2013149008A2
(en)
*
|
2012-03-30 |
2013-10-03 |
Givaudan, S.A. |
Improvements in or relating to organic compounds
|
|
US10856563B2
(en)
|
2012-03-30 |
2020-12-08 |
Givaudan S.A. |
N-acyl-amino acid derivatives for improvement of the flavor profile of edible compositions
|
|
SG11201405413SA
(en)
|
2012-03-30 |
2014-10-30 |
Givaudan Sa |
N-acyl derivatives of gamma amino - butyric acid and and beta alanine as food flavouring compounds
|
|
US10582715B2
(en)
|
2012-03-30 |
2020-03-10 |
Givaudan Sa |
Powder flavour composition
|
|
CN104219964B
(zh)
|
2012-03-30 |
2016-09-21 |
奇华顿股份有限公司 |
作为食品加香化合物的n-酰基脯氨酸衍生物
|
|
JP6320367B2
(ja)
|
2012-03-30 |
2018-05-09 |
ジボダン エス エー |
食品フレーバー付与化合物としてのｎ−アシル化メチオニン誘導体
|
|
BR122020006518B1
(pt)
|
2012-03-30 |
2022-02-22 |
Givaudan Sa |
Composição de sabor
|
|
GB201221329D0
(en)
|
2012-11-27 |
2013-01-09 |
Avexxin As |
Dermatitis treatment
|
|
US11351139B2
(en)
|
2013-02-28 |
2022-06-07 |
Basf As |
Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
|
|
CA2906864A1
(en)
|
2013-03-15 |
2014-09-18 |
Ampio Pharmaceuticals, Inc. |
Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
|
|
GB201317424D0
(en)
|
2013-10-02 |
2013-11-13 |
Givaudan Sa |
Improvements in or relating to organic compounds
|
|
EP3057448B1
(en)
|
2013-10-02 |
2017-12-06 |
Givaudan S.A. |
Organic compounds having taste-modifying properties
|
|
EP3057446B1
(en)
|
2013-10-02 |
2017-12-06 |
Givaudan S.A. |
Organic compounds having taste-modifying properties
|
|
CN105636934B
(zh)
|
2013-10-02 |
2019-03-29 |
奇华顿股份有限公司 |
N-酰化的2-氨基异丁酸化合物和包含它们的香味组合物
|
|
WO2015050535A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
EP3057447B1
(en)
|
2013-10-02 |
2017-12-06 |
Givaudan S.A. |
Organic compounds having taste-modifying properties
|
|
WO2015048991A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan Sa |
Organic compounds having taste-modifying properties
|
|
GB201409363D0
(en)
|
2014-05-27 |
2014-07-09 |
Avexxin As |
Skin cancer treatment
|
|
EP4066836A1
(en)
|
2014-08-18 |
2022-10-05 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
|
AU2016256552B2
(en)
|
2015-04-28 |
2021-04-01 |
Pronova Biopharma Norge As |
Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis
|
|
EP3310375A4
(en)
|
2015-06-22 |
2019-02-20 |
Ampio Pharmaceuticals, Inc. |
USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
|
|
WO2017156164A1
(en)
|
2016-03-09 |
2017-09-14 |
Board Of Regents, The University Of Texas System |
20-hete receptor (gpr75) antagonists and methods of use
|
|
GB201604316D0
(en)
|
2016-03-14 |
2016-04-27 |
Avexxin As |
Combination therapy
|
|
CA3037582A1
(en)
|
2016-09-21 |
2018-03-29 |
Avexxin As |
Pharmaceutical composition
|
|
IL308604B2
(en)
|
2017-12-06 |
2025-08-01 |
Basf As |
Fatty acid derivatives for treating non-alcoholic steatohepatitis
|